Advanced search
Publication Cover
Scandinavian Journal of Urology and Nephrology Volume 35, 2001 - Issue 4
Submit an article Journal homepage
11
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Urine Tissue-Polypeptide-Specific Antigen (TPS) as a Marker for Bladder Cancer

Hans Boman, Hans Hedelin, Sten Holmäng From the Department of Surgery, Alingsa's Hospital, Alingsas
Pages 270-274 | Published online: 09 Jul 2009

References

  • Ramakumar S, Bhuiyan J, Besse JA, et al. Comparison of screening methods in the detection of bladder cancer. J Urol 1999; 161: 388�94.
  • Rydlander L, Ziegler E, Bergman T, et al. Molecular characterization of a tissue-polypeptide-speci. c-antigen epitope and its relationship to human cytokeratin 18. Eur J Biochem 1996; 241: 309�14.
  • Glimelius B, Hoffman K, Einarsson R, Pa� hlman L, Graf W. Monitoring palliative chemotherapy in advanced gastrointestinal cancer using serial tissue polypeptide speci. c antigen (TPS) measurements. Acta Oncologica 1996; 35: 141�8.
  • Van Dalen A, Barak V, Cremaschi A, et al. The prognostic signi. cance of increasing marker levels in metastatic breast cancer patients with clinically complete remission, partial remission or stable disease. Int J Biol Markers 1998; 13: 10�15.
  • Harlozinska A, Sedlaczek P, van Dalen A, Rozdolski K, Einarsson R. TPS and CA 125 levels in serum, cyst � uid and ascites of patients with epithelial ovarian neoplasms. Anticancer Res 1997; 17: 4473�8.
  • Halim A-B, El-Ahmady O, Hamza S, Aboul-Ela M, Oehr P. Serum TPS versus TPA in Egyptian bladder cancer patients. Int J Biol Markers 1993; 8: 221�6.
  • Yao W-J, Chang C-J, Chan S-H, Chow N-H, Cheng H-L, Tzai T-S, Lin S-N. Signi. cance of urinary tissue polypeptide speci. c antigen (TPS) determination in patients with urothelial carcinoma. Anticancer Res 1995; 15: 2819�24.
  • El-Ahmady O, Eissa S, Gamal El-Din A, van Dalen A, van Caubergh RD. TPS in serum and urine of Egyptian bladder cancer patients. Oncology Reports 1994; 1: 519� 21.
  • El-Ahmady O, Halim A-B, Gamal El-Din A. The clinical value of CYFRA21-1 in bladder cancer patients: Egyptian experience. Anticancer Res 1999; 19: 2603�8.
  • Stieber P, Schmeller N, Schambeck CH, et al. Clinical relevance of CYFRA 21-1, TPA-IRMA and TPA-LIAmatin urinary bladder cancer. Anticancer Res 1996; 16: 3793�8.
  • Sa�nchez-Carbayo M, Herrero E, Meg��as J, Mira A, Soria F. Comparative sensitivity of urinary CYFRA 21–1,turinary bladder cancer antigen, tissue polypeptideantigen and NMP22 to detect bladder cancer. J Urol1999; 162: 1951�6.Scand J

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.